Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

The CTGF gene -945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes.

Patel SK, Wai B, Macisaac RJ, Grant S, Velkoska E, Ord M, Panagiotopoulos S, Jerums G, Srivastava PM, Burrell LM.

Cardiovasc Diabetol. 2012 Apr 26;11:42. doi: 10.1186/1475-2840-11-42.

2.

Cardiac function in renovascular hypertensive patients with and without renal dysfunction.

Khangura KK, Eirin A, Kane GC, Misra S, Textor SC, Lerman A, Lerman LO.

Am J Hypertens. 2014 Mar;27(3):445-53. doi: 10.1093/ajh/hpt203. Epub 2013 Oct 25.

3.

Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study.

De Jong KA, Czeczor JK, Sithara S, McEwen K, Lopaschuk GD, Appelbe A, Cukier K, Kotowicz M, McGee SL.

Cardiovasc Diabetol. 2017 Feb 8;16(1):21. doi: 10.1186/s12933-017-0504-z. Erratum in: Cardiovasc Diabetol. 2017 Apr 20;16(1):53.

4.

Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.

Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, Marre S, Cassottana P, Lucà S, Vettoretti S, Borrelli S, Conte G, Minutolo R.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):271-9. doi: 10.2215/CJN.06980615. Epub 2015 Dec 14.

5.

Annual deterioration of renal function in hypertensive patients with and without diabetes.

Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S.

Vasc Health Risk Manag. 2017 Jun 26;13:231-237. doi: 10.2147/VHRM.S135253. eCollection 2017.

6.

The association of genetic variants of type 2 diabetes with kidney function.

Franceschini N, Shara NM, Wang H, Voruganti VS, Laston S, Haack K, Lee ET, Best LG, Maccluer JW, Cochran BJ, Dyer TD, Howard BV, Cole SA, North KE, Umans JG.

Kidney Int. 2012 Jul;82(2):220-5. doi: 10.1038/ki.2012.107. Epub 2012 Apr 18.

7.

Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects.

Asp AM, Wallquist C, Rickenlund A, Hylander B, Jacobson SH, Caidahl K, Eriksson MJ.

Clin Physiol Funct Imaging. 2015 May;35(3):223-30. doi: 10.1111/cpf.12154. Epub 2014 Apr 21.

8.

Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.

Ulasi II, Arodiwe EB, Ijoma CK.

Ethn Dis. 2006 Autumn;16(4):859-64.

PMID:
17061738
9.

Aquaporin 11 variant associates with kidney disease in type 2 diabetic patients.

Choma DP, Vanacore R, Naylor H, Zimmerman IA, Pavlichenko A, Pavlichenko A, Foye L, Carbone DP, Harris RC, Dikov MM, Tchekneva EE.

Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F416-25. doi: 10.1152/ajprenal.00295.2015. Epub 2015 Dec 30.

10.

Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors?

Masugata H, Senda S, Goda F, Yamagami A, Okuyama H, Kohno T, Hosomi N, Yukiiri K, Noma T, Imai M, Kiyomoto H, Nishiyama A, Kohno M.

Clin Exp Hypertens. 2010 Jan;32(2):113-20. doi: 10.3109/10641960902993145.

PMID:
20374184
11.

Differential associations between glomerular filtration rate and duration of obesity depending on the presence or absence of left ventricular diastolic dysfunction.

Ybarra J, Sánchez-Hernández J, Vilallonga R, Romeo JH.

Eur J Intern Med. 2016 Jul;32:47-52. doi: 10.1016/j.ejim.2016.02.016. Epub 2016 Feb 28.

PMID:
26935097
12.

Association of Left Ventricular Hypertrophy With a Faster Rate of Renal Function Decline in Elderly Patients With Non-End-Stage Renal Disease.

Shi HT, Wang XJ, Li J, Song GF, Huang ZY, Guo XY, Guo JJ, Lv ZY, Li HW, Ge JB, Cui J, Qi GM.

J Am Heart Assoc. 2015 Nov 9;4(11). pii: e002213. doi: 10.1161/JAHA.115.002213.

13.

Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study.

Liu JE, Robbins DC, Palmieri V, Bella JN, Roman MJ, Fabsitz R, Howard BV, Welty TK, Lee ET, Devereux RB.

J Am Coll Cardiol. 2003 Jun 4;41(11):2022-8.

14.

Association of a polymorphism of the interleukin 6 receptor gene with chronic kidney disease in Japanese individuals.

Horibe H, Fujimaki T, Oguri M, Kato K, Matsuoka R, Abe S, Tokoro F, Arai M, Noda T, Watanabe S, Yamada Y.

Nephrology (Carlton). 2015 Apr;20(4):273-8. doi: 10.1111/nep.12381.

PMID:
25524550
15.

Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease.

Nardi E, Palermo A, Mulè G, Cusimano P, Cottone S, Cerasola G.

J Hum Hypertens. 2011 Mar;25(3):144-51. doi: 10.1038/jhh.2010.96. Epub 2010 Oct 14.

PMID:
20944658
16.

Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.

Michels M, Soliman OI, Kofflard MJ, Hoedemaekers YM, Dooijes D, Majoor-Krakauer D, ten Cate FJ.

JACC Cardiovasc Imaging. 2009 Jan;2(1):58-64. doi: 10.1016/j.jcmg.2008.08.003.

17.

Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.

Rojek A, Cielecka-Prynda M, Przewlocka-Kosmala M, Laczmanski L, Mysiak A, Kosmala W.

J Hum Hypertens. 2014 Sep;28(9):557-63. doi: 10.1038/jhh.2014.26. Epub 2014 Apr 10.

PMID:
24718382
19.

Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.

Mohsen A, Brown R, Hoefield R, Kalra PA, O'Donoghue D, Middleton R, New D.

J Nephrol. 2012 May-Jun;25(3):384-93. doi: 10.5301/jn.5000062.

PMID:
22241634
20.

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2013 Oct;17(5):730-742. doi: 10.1007/s10157-012-0758-4. Epub 2013 Jan 16. Retraction in: Clin Exp Nephrol. 2017 Dec;21(6):1146.

Supplemental Content

Support Center